CASGEVY™ approved for the treatment of patients 12 years of age and older with sickle cell disease (SCD) and transfusion-dependent beta ...

Doctors stress the importance of awareness and testing for thalassemia, a genetic blood disorder affecting children, as cases continue to rise due to lack of information and government programs.

With new approvals on the horizon and the closely watched Casgevy launch picking up steam in sickle cell disease and beta ...

Results from Phase 3 ENERGIZE-T Study of Mitapivat in Transfusion-dependent Thalassemia will be Presented in Oral Session –– Tebapivat Phase 1 ...

CASGEVY approved for the treatment of patients 12 years of age and older with sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT) in Switzerland and Canada- -45 authorized treat ...

Doctors & patients confirm acute shortage of the drug in hospitals, even as manufacturer Novartis maintains there is no ...

My son won’t need monthly hospital trips anymore.""I’m happy to be better and grateful to the doctors," said Vuong, touching ...

Beam Therapeutics enrolls 35 patients in BEACON trial for BEAM-101 in sickle cell disease, with promising early safety and ...

World Thalassemia Day was observed on Wednesday. This year’s theme is “Empowering Lives, Embracing Progress: Equitable and Accessible Thalassemia Treatment for All’’. International Thalassemia Day is ...

My name is Hemanti Devi and I am raising funds for my son, Jhari soren who is suffering from Thalassemia major and is undergoing treatment at NH Mazumdar Shaw Medical Centre, Bangalore. The family has ...